Wells Fargo & Company Gsk PLC Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $6.34 Million - $7.21 Million	150,870 Added 4.38%	3,595,382 $157 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $6.2 Million - $7.36 Million	-154,160 Reduced 4.28%	3,444,512 $150 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $2.73 Million - $3.18 Million	70,177 Added 1.99%	3,598,672 $159 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $18.8 Million - $20.9 Million	-483,461 Reduced 12.05%	3,528,495 $135 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $5.25 Million - $5.96 Million	-143,781 Reduced 3.46%	4,011,956 $160 Million
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $17.5 Million - $20.4 Million	-509,985 Reduced 10.93%	4,155,737 $148 Million
Q4 2020 Feb 09, 2021	SELL	$34.07 - $39.94 $51.8 Million - $60.7 Million	-1,519,389 Reduced 24.57%	4,665,722 $172 Million
Q3 2020 Nov 05, 2020	BUY	$38.11 - $42.99 $14 Million - $15.7 Million	366,291 Added 6.29%	6,185,111 $233 Million
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $4.44 Million - $5.11 Million	-117,158 Reduced 1.97%	5,818,820 $237 Million
Q1 2020 May 14, 2020	BUY	$32.47 - $48.83 $193 Million - $290 Million	5,935,978 New	5,935,978 $225 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.